JPS57203087A - Production of antibacterial - Google Patents

Production of antibacterial

Info

Publication number
JPS57203087A
JPS57203087A JP57075302A JP7530282A JPS57203087A JP S57203087 A JPS57203087 A JP S57203087A JP 57075302 A JP57075302 A JP 57075302A JP 7530282 A JP7530282 A JP 7530282A JP S57203087 A JPS57203087 A JP S57203087A
Authority
JP
Japan
Prior art keywords
compound
formula
formulai
salt
cephalosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57075302A
Other languages
English (en)
Other versions
JPS5917117B2 (ja
Inventor
Takayuki Naito
Jun Okumura
Hideaki Hoshi
Hajime Kamaike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRISTOL MAYERS KENKYUSHO KK
Bristol Banyu Research Institute Ltd
Original Assignee
BRISTOL MAYERS KENKYUSHO KK
Bristol Banyu Research Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRISTOL MAYERS KENKYUSHO KK, Bristol Banyu Research Institute Ltd filed Critical BRISTOL MAYERS KENKYUSHO KK
Publication of JPS57203087A publication Critical patent/JPS57203087A/ja
Publication of JPS5917117B2 publication Critical patent/JPS5917117B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP57075302A 1973-09-04 1982-05-07 抗菌剤の製法 Expired JPS5917117B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US394367A US3907786A (en) 1973-09-04 1973-09-04 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts
US411559 1989-09-22
US394367 1995-02-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP49100841A Division JPS5924158B2 (ja) 1973-09-04 1974-09-04 抗菌剤の製法

Publications (2)

Publication Number Publication Date
JPS57203087A true JPS57203087A (en) 1982-12-13
JPS5917117B2 JPS5917117B2 (ja) 1984-04-19

Family

ID=23558661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57075302A Expired JPS5917117B2 (ja) 1973-09-04 1982-05-07 抗菌剤の製法

Country Status (4)

Country Link
US (1) US3907786A (ja)
JP (1) JPS5917117B2 (ja)
BE (1) BE819540A (ja)
ZA (1) ZA745531B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
US4082912A (en) * 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
US4198506A (en) * 1976-06-30 1980-04-15 Bristol-Myers Company 2-Carboxyalkyl-2,3-dihydro-6-mercapto-s-triazolo[4,3-b]-pyridazin-3-ones
US4112228A (en) * 1976-07-13 1978-09-05 Bristol-Myers Company 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives
GB1572201A (en) * 1977-04-05 1980-07-23 Bristol Myers Co Cephalosporins
US4118563A (en) * 1977-11-25 1978-10-03 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US4448958A (en) * 1982-10-20 1984-05-15 Bristol-Myers Company Purification of ceforanide
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
DE3689762T2 (de) * 1985-12-13 1994-08-18 Takeda Chemical Industries Ltd Antibakterielle Verbindungen, ihre Herstellung und Verwendung.
CN102453044B (zh) * 2010-10-20 2014-06-18 周小明 一种利用微反应技术制备比阿培南的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766175A (en) * 1971-05-11 1973-10-16 R & L Molecular Research Ltd Certain 7 - (o-aminomethylphenylacetamido) - 3-((heterocyclylthio)methyl)ceph-3-em-4-carboxylic acids

Also Published As

Publication number Publication date
ZA745531B (en) 1975-08-27
US3907786A (en) 1975-09-23
JPS5917117B2 (ja) 1984-04-19
BE819540A (fr) 1975-03-04

Similar Documents

Publication Publication Date Title
US3708479A (en) Acyloxymethyl esters of alpha-ureidocyclo-hexadie nylalkylene-cephalosporins
JPS5686187A (en) 7-acylamino-3-vinylcephalosporanic acid derivative and its preparation
JPS57203087A (en) Production of antibacterial
JPS5543011A (en) 7-halothiazolylalkoxyiminoacetamido-3-cephem compound
ES8700861A1 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
JPS56118085A (en) 2-methylcephalosporin derivative and its preparation
JPS5653656A (en) Quinoline derivative and its preparation
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
GB1460916A (en) Preparation of 3-thiolated-7-acylamido-cephalosporanic acid derivatives
JPS5533500A (en) 3,7-disubstituted-3-cephem-4-carboxylic acid, its salt, their preparation, and preventive and remedy for microbism
DE3419013A1 (de) Neue cephalosporine und verfahren zu ihrer herstellung
ZA865255B (en) Arylethanol-hydroxylamines,process for their preparation and their use for promotion of production
JPS5746990A (en) Novel cephalexin derivative and its preparation
JPS57114556A (en) Novel peptide compound and its preparation
GB1437906A (en) Compositions for and method of promoting animal growth
ES8502697A1 (es) Un procedimiento para la produccion de derivados del acido 2-(2-aminotiazol-4-il) glioxilico
JPS56142282A (en) Penem-3-carboxylic acid derivative and its preparation
ES8200371A1 (es) Procedimiento para la preparacion de derivados tiazolil-n- substituidos de cefalosporinas oxi-imino-substituidas
US3682981A (en) 2-amino-2-(1,4-cyclohexadienyl) acetic acid
IE40517L (en) 3 - heterocyclic thiomethyl cephalosporins
IE42191L (en) 7ó-methoxy cephalosporin compounds.
EP0076452A3 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
IE43666L (en) Cephalosporin derivatives.
JPS57145845A (en) Novel peptide and its preparation
IE39830B1 (en) 7-(substituted 1-cyclohexenyl and 1,4 cyclohexadienyl-acetamido)-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids